CCR1 inhibition sensitizes multiple myeloma cells toglucocorticoid therapy
Bert Luyckx, Maaike Van Trimpont, Fien Declerck, Eleni Staessens, Annick Verhee, Sara T’Sas, Sven Eyckerman, Fritz C. Offner, Pieter Van Vlierberghe, Steven Goosens, Dorien Clarisse, Karolien De Bosscher
This study shows that inhibiting CCR1 enhances the effectiveness of glucocorticoid therapy in multiple myeloma by reversing resistance mechanisms.
Pharmacological Research · Mar 23, 2025Peer-reviewedCancer Biology